Harrow Health, Inc.
Harrow Health, Inc. (HROW) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HROW · as of Jun 8, 2026
Key Statistics
Explore Harrow Health, Inc. Data
hrow stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 10 · Buy rate: 100.0%
The HROW analyst consensus is Buy, based on ratings from 10 Wall Street analysts over the past 3 months. The average 12-month price target is $73.67, representing +120.31% upside from the current price of $33.44.
Competitors & Peers
hrow competitorsHROW
ALVO
AMPH
BLFS
COLL
DVAXStock Performance
Full HistoryAbout Harrow Health, Inc.
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatmen…
what is harrow health, inc. · hrow stock overview · harrow health, inc. company profile · who is harrow health, inc. ceo · hrow NASDAQ · harrow health, inc. headquarters · harrow health, inc. business segments
About Stock Overview & Key Data
Harrow Health, Inc. (HROW) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NASDAQ since Sep 28, 2007. As of the latest trading session, HROW stock price is $33.44, with a market capitalization of $1.2B. The stock has returned +10.26% over the past 12 months and -32.16% year-to-date.
According to 10 Wall Street analysts, the consensus rating for Harrow Health, Inc. stock is Buy, with an average 12-month price target of $73.67. In fiscal year 2025, Harrow Health, Inc. reported revenue of $272.3M and net income of -$5.1M. For detailed data — including Harrow Health, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Harrow Health, Inc. (HROW) stock price is $33.44. The stock is traded on NASDAQ under the ticker symbol HROW. The 52-week range is $27.76 – $54.85.